Bioequivalence Study of Iron Sucrose Azad vs Venofer in Healthy Volunteers

Phase 1, randomised, open-label trial of iron sucrose in iron deficiency anemia (IDA) (2 arms), sponsored by AZAD Pharma AG. Primary endpoints: Peak Plasma Concentration of Baseline Corrected Total Serum Iron and Transferrin-bound Iron at 24 hours and Area Under the Plasma Concentration vs Time Curve of Baseline Corrected Total Serum Iron and Transferrin-bound Iron at 24 hours. Started Nov 2014; status: completed.